Clinical trials: Transfusion-dependent Non-severe Aplastic Anemia
Aplastic Anemia
A Study of Romiplostim for the Treatment of Refractory Transfusion-dependent NSAA
Efficacy and safety of Romiplostim in the treatment of refractory transfusion-dependent NSAA.
- Trial name
- NCT06535685
- Testing
- Romiplostim
- Where
- China
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Peking Union Medical College Hospital